EP1214404A4 - Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions - Google Patents

Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions

Info

Publication number
EP1214404A4
EP1214404A4 EP00966717A EP00966717A EP1214404A4 EP 1214404 A4 EP1214404 A4 EP 1214404A4 EP 00966717 A EP00966717 A EP 00966717A EP 00966717 A EP00966717 A EP 00966717A EP 1214404 A4 EP1214404 A4 EP 1214404A4
Authority
EP
European Patent Office
Prior art keywords
embryonic
stem
methods
cell lines
tissue culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00966717A
Other languages
German (de)
French (fr)
Other versions
EP1214404A1 (en
Inventor
James Robl
Jose Cibelli
Steven L Stice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Massachusetts UMass
Original Assignee
University of Massachusetts UMass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Massachusetts UMass filed Critical University of Massachusetts UMass
Publication of EP1214404A1 publication Critical patent/EP1214404A1/en
Publication of EP1214404A4 publication Critical patent/EP1214404A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/04—Cells produced using nuclear transfer
EP00966717A 1999-09-14 2000-09-14 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions Withdrawn EP1214404A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39536899A 1999-09-14 1999-09-14
PCT/US2000/025090 WO2001019977A1 (en) 1999-09-14 2000-09-14 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
US395368 2002-07-12

Publications (2)

Publication Number Publication Date
EP1214404A1 EP1214404A1 (en) 2002-06-19
EP1214404A4 true EP1214404A4 (en) 2003-09-03

Family

ID=23562752

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00966717A Withdrawn EP1214404A4 (en) 1999-09-14 2000-09-14 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions

Country Status (10)

Country Link
EP (1) EP1214404A4 (en)
JP (1) JP2003525031A (en)
CN (1) CN1379814A (en)
AU (1) AU7701900A (en)
BR (1) BR0013999A (en)
CA (1) CA2384413A1 (en)
IL (2) IL148547A0 (en)
MX (1) MXPA02002744A (en)
NZ (1) NZ517609A (en)
WO (1) WO2001019977A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696404B2 (en) 1996-08-19 2010-04-13 Advanced Cell Technology, Inc. Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
CA2383776A1 (en) * 1999-09-07 2001-03-15 Advanced Cell Technology, Inc. Method for generating immune-compatible cells and tissues using nuclear transfer techniques
AU782385B2 (en) 1999-10-15 2005-07-21 Advanced Cell Technology, Inc. Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells
WO2001046401A1 (en) * 1999-12-20 2001-06-28 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Embryonic or stem-like cells produced by cross species nuclear transplantation
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999005266A2 (en) * 1997-07-26 1999-02-04 Wisconsin Alumni Research Foundation Trans-species nuclear transfer
WO2001046401A1 (en) * 1999-12-20 2001-06-28 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Embryonic or stem-like cells produced by cross species nuclear transplantation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
EP0934403A4 (en) * 1996-08-19 2001-03-14 Univ Massachusetts Embryonic or stem-like cell lines produced by cross species nuclear transplantation
IL138201A0 (en) * 1998-03-02 2001-10-31 Univ Massachusetts Embryonic or stem-like cell lines produced by cross-species nuclear transplantation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999005266A2 (en) * 1997-07-26 1999-02-04 Wisconsin Alumni Research Foundation Trans-species nuclear transfer
WO2001046401A1 (en) * 1999-12-20 2001-06-28 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Embryonic or stem-like cells produced by cross species nuclear transplantation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"CLAIM OF HUMAN-COW EMBRYO GREETED WITH SKEPTICISM", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 282, no. 1, 20 November 1998 (1998-11-20), pages 1390 - 1391, XP002930979, ISSN: 0036-8075 *
BLERKOM VAN J ET AL: "MITOCHONDRIAL TRANSFER BETWEEN OOCYTES: POTENTIAL APPLICATIONS OF MITOCHONDRIAL DONATION AND THE ISSUE OF HETEROPLASMY", HUMAN REPRODUCTION, IRL PRESS, OXFORD, GB, vol. 13, no. 10, 1998, pages 2857 - 2868, XP001002313, ISSN: 0268-1161 *
DOMINKO T ET AL: "BOVINE OOCYTE CYTOPLASM SUPPORTS DEVELOPMENT OF EMBRYOS PRODUCED BYNUCLEAR TRANSFER OF SOMATIC CELL NUCLEI FROM VARIOUS MAMMALIAN SPECIES", BIOLOGY OF REPRODUCTION, SOCIETY FOR THE STUDY OF REPRODUCTION, CHAMPAIGN, IL, US, vol. 60, no. 6, June 1999 (1999-06-01), pages 1496 - 1502, XP000920565, ISSN: 0006-3363 *
See also references of WO0119977A1 *

Also Published As

Publication number Publication date
JP2003525031A (en) 2003-08-26
MXPA02002744A (en) 2003-07-21
EP1214404A1 (en) 2002-06-19
AU7701900A (en) 2001-04-17
IL148547A (en) 2009-09-01
IL148547A0 (en) 2002-09-12
CN1379814A (en) 2002-11-13
CA2384413A1 (en) 2001-03-22
WO2001019977A1 (en) 2001-03-22
BR0013999A (en) 2002-05-21
WO2001019977A9 (en) 2002-09-26
NZ517609A (en) 2004-02-27

Similar Documents

Publication Publication Date Title
NO20022180D0 (en) Hematopoietic differentiation of human embryonic stem cells
IL207268A0 (en) Methods of culture systems of preparing feeder cells - free, xeno - free human embryonic stem cells and stem cell cultures prepared using same
IL128348A0 (en) Embryonic or stem-like cell lines produced by cross species nuclear transplantation
NZ336612A (en) Cloning using donor nuclei from proliferating somatic cells
MXPA02004333A (en) Use of haploid genomes for genetic diagnosis, modification and multiplication.
AU3914300A (en) Cell culture apparatus and method for culturing cells
NO20033396D0 (en) Improved in vitro method for culturing mammalian cells for autologous cell implantation / transplantation methods
PL356025A1 (en) Sugarbeet regeneration and transformation
NZ513888A (en) Embryonic or stem-like cell lines produced by cross species nuclear transplantation
EP1385933A4 (en) Culture medium for cell growth and transfection
PL328922A1 (en) Culture medium for growing mammal tissue cells
EP1017423A4 (en) Cloning pigs using donor nuclei from differentiated cells
WO2002072762A3 (en) Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
GB0706626D0 (en) Medium and culture of embryonic stem cells
IL150065A0 (en) Embryonic or stem-like cells produced by cross species nuclear transplantation
IL148547A0 (en) Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
GB2386905B (en) Carrier for cell culture and method for culturing cells
EP1238059A4 (en) Long-term cell culture compositions and genetically modified animals derived therefrom
IL149071A0 (en) Preparation and selection of donor cells for nuclear transplantation
IL138201A0 (en) Embryonic or stem-like cell lines produced by cross-species nuclear transplantation
EP1513927A4 (en) Generation of histocompatible tissues using nuclear transplantation
MXPA02001400A (en) Avian blastodermal cell lines.
PL329830A1 (en) Method of and apparatus for controlling growth of procariotic and eucariotic cells as well as activity of enzymes and functions of genes in biotechnological laboratory cell cultures and in natural living organisms
ITUD950066A0 (en) PROCEDURE FOR THE PREPARATION AND STORAGE OF CELL CULTURES, OR PARTS OF CELLS, IN THE READY STATE FOR BIOLOGICAL ASSAYMENTS
AU2003274535A1 (en) Cell culture supplement for the in vitro cultivation of cells and a method for culturing cells

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020408

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ROBL, JAMES

Inventor name: STICE, STEVEN, L.

Inventor name: CIBELLI, JOSE

A4 Supplementary search report drawn up and despatched

Effective date: 20030717

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 5/02 B

Ipc: 7C 12N 5/00 B

Ipc: 7C 12N 5/08 B

Ipc: 7C 12N 15/00 A

Ipc: 7A 01K 67/027 B

Ipc: 7A 61K 48/00 B

17Q First examination report despatched

Effective date: 20031107

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040518